Clinical Microbiology: Open Access

Surveillance of critical hospital-acquired infections; MRSA and VRE: 3 years retrospective study

4^th International Conference on Clinical Microbiology and Microbial Genomics

October 05-07, 2015 Philadelphia, USA

Aylin Uskudar Guclu, Mustafa Guney, Ali Korhan Sig, Abdullah Kilic, H Cem Gul, Mehmet Baysallar and Bulent Besirbellioglu

Gulhane Military Medical Academy, Turkey

Posters-Accepted Abstracts: Clin Microbiol

Abstract:

Vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) have emerged as important nosocomial pathogens. Active surveillance of MRSA and VRE includes the detection and observing patients who are asymptomatically colonized with these microorganisms. Precautions for both carriers and infected patients target to reduce the spread of MRSA and VRE in a hospital and decrease hospital-acquired infections due to these organisms. The aim of this study is to evaluate the 3 years-surveillance program of Gulhane Military Medical Academy and Faculty of Medicine Training Hospital retrospectively. Rectal swab samples for screening of VRE and axillar, inguinal and nasal swab samples for screening MRSA were collected from inpatients. VRE selective medium (Enterococcus agar containing 6μg of vancomycin and 8μg of seftazidime per ml) and MRSA chrom-agar were used to screen related isolates. Identification and antimicrobial susceptibilities of bacterial isolates were performed by both conventional methods and automated microbiology system, Phoenix 100 (BD). From 1760 rectal swab samples, 174 (100 in 2012; 54 in 2013 and 20 in 2014) VRE were isolated from 1760 axillar, inguinal and nasal swab samples, 42 (10 in 2012; 10 in 2013 and 22 in 2014) MRSA were isolated. Hospital-acquired MRSA rates in 2012, 2013 and 2014 were 1.8%, 1.1% and 1.3%; Hospital-acquired VRE rates were 1.2%, 0% and 0.2% respectively. An expanded VRE vs. MRSA surveillance program that encompassed all patients hospitalized within 3 years showed that nosocomial spread of VRE and MRSA can be prevented and can lead to decrease in hospital-acquired infections.

Biography :

Aylin Uskudar Guclu has completed her PhD program in Biological Sciences in Middle East Technical University in 2011. She has been educating on Clinical Microbiology PhD program in Gulhane Military Medical Academy since 2013. She has been working as Biologist in the department of Clinical Microbiology of the same Academy, since 2002. She is a Member of KLIMUD (Clinical Microbiology and Expertise Association in Turkey) and Turkish Microbiology Community (TMC).

Email: auguclu@gata.edu.tr